Comparison of in vivo fate and immunogenicity of hepatitis B surface antigen incorporated in cationic and neutral liposomes

Journal of Microencapsulation

Volumn 17, Issue 3, 2000, Pages 297-306

  Kim, C K ^a   Jeong, E J ^b   Kim, M H ^a  

^a Seoul National University   (South Korea)

^b CJ Corporation   (South Korea)

Author keywords

Cationic liposomes; Hepatitis B; Immunoadjuvant; Neutral liposomes; Surface antigen; Vaccine carrier

Indexed keywords

DRUG CARRIER; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG UPTAKE; IMMUNOGENICITY; INJECTION SITE; LYMPHOID TISSUE; MALE; NONHUMAN; RAT; SEROCONVERSION; SPLEEN; VACCINE PRODUCTION;

EID: 0034092940     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/026520400288274     Document Type: Article

References (20)

1. ALVING, C. R., KOULCHIN, V., GLENN, G. M., and RAO, M., 1995, Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunological Reviews, 145, 5-31.
2. AUDER, C., RAMIREZ, J., SOLER, E., and CARREIRA, J., 1991, Liposomes as carriers for allergy immunotherapy. Clinical and Experimental Allergy, 21, 139-144.
3. BEI, R., GUPTILL, V., MASUELLI, L., KASHMIRI, S. V., MURARO, R., FRATI, L., SCHLOM, J., and KANTOR, J., 1998, The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. Journal of Immunotherapy, 21, 159-169.
4. COUVREUR, P., FATTAL, E., and ANDREMONT, A., 1991, Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharmaceutical Research, 8, 1079-1086.
5. FATUNMBI, O. O., NEWMAN, J. A., SIVANANDAN, V., and HALVORSON, D. A., 1992, Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine, 10, 623-626.
6. FRIEDE, M., MULLER, S., BRIAND, J. P., UAN REGENMORTEL, M. H., and SCHUBER, F., 1993, Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. Molecular Immunology, 30, 539-547.
7. GLUCK, R., 1995, Liposomal presentation of antigens for human vaccines. Pharmaceutical Biotechnology, 6, 325-345.
8. GREGORIADIS, G., 1994, The immunological adjuvant and vaccine carrier properties of liposomes. Journal of Drug Targeting, 2, 351-356.
9. GUPTA, P. K., and HUNG, C. T., 1989, Quantitative evaluation of targeted drug delivery systems. International Journal of Pharmaceutics, 56, 217-226.
10. 3H-methotrexate-human serum albumin conjugates in mice. Drug Development and Industrial Pharmacy, 19, 961-970.
11. KIM, C.-K., and JEONG, E. J., 1995, Development of dried liposomes as effective immunoadjuvant for hepatitis B surface antigen. International Journal of Pharmaceutics, 115, 193-199.
12. KIM, C.K., and JEONG, E. J., 1997, Enhanced lymph node delivery and immunogenicity of hepatitis B surface antigen incorporated in galactosylated liposomes. International Journal of Pharmaceutics, 147, 143-151.
13. LAMBROS, M. P., SCHAFER, F., BLACKSTOCK, R., and MURPHY, J. W., 1998, Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine. Journal of Pharmaceutical Sciences, 87, 1144-1148.
14. LATIF, N., and BACHHAWAT, B. K., 1984, The effect of surface charges of liposomes in immunopotentiation. Bioscience Reports, 4, 99-107.
15. MANESIS, E. K., CAMERON, C. H., and GREGORIADIS, G., 1979, Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. Biochemical Society Transactions, 7, 678-690.
16. NAKANISHI, T., KUNISAWA, J., HAYASHI, A., TSUTSUMI, Y., KUBO, K., NAKAGAWA, S., FUJIWARA, H., HAMAOKA, T., and MAYUMI, T., 1997, Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochemical and Biophysical Research Communications, 240, 793-797.
17. NEW, R. R. C., 1990, Preparation of liposomes. Liposomes; A practical Approach (New York: IRL Press), pp. 33-104.
18. PHILLIPS, N. C., GAGNE, L., IVANOFF, N., and RIVEAU, G., 1996, Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine, 14, 898-904.
19. POL, S., 1995, Immunotherapy of chronic hepatitis B by anti HBV vaccine. Biomedical Pharmacotherapy, 49, 105-109.
20. STEWART, J. C. M., 1980, Colorimetric determination of phospholipids with ammonium ferrocyanate. Analytical Biochemistry, 104, 10-14.